Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research
Olverembatinib, a novel multikinase inhibitor, has shown significant antitumor activity in patients with advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors (GISTs). In a multicenter phase 1b study, it demonstrated a median progression-free survival of 25.7 months and a clinical benefit rate of 84.6%. The study highlights olverembatinib's ability to modulate lipid metabolism and inhibit tumorigenic pathways, marking it as a promising candidate for early investment in oncology.
Towards practical point-of-care quick, ubiquitous, integrated, cost-efficient molecular diagnostic Kit (QUICK) PCR for future pandemic response
QUICK-PCR是一种快速、普遍、集成和成本效益高的分子诊断工具，旨在应对未来的疫情。文章总结了PCR技术的最新进展，强调了样本准备、热循环和结果读取方法的创新，指出其在资源有限地区的应用潜力。通过整合最新技术，QUICK-PCR能够提高诊断的可及性和效率，为公共卫生危机提供有效的解决方案。
STAT+: Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot
Azalea Therapeutics是一家由诺贝尔奖得主Jennifer Doudna创办的生物技术公司，专注于开发创新的CAR-T治疗方法。该公司通过单次输注将患者的免疫细胞转化为抗癌和自身免疫疾病的战斗细胞，旨在简化现有CAR-T疗法的复杂过程。Azalea最近成功筹集了8200万美元的资金，其中包括1700万美元的种子轮融资和6500万美元的A轮融资，显示出其在基因编辑领域的潜力和市场需求。
Towards pharmacological prevention of Alzheimer disease
文章探讨了阿尔茨海默病的药物预防策略，强调了生物标志物在早期检测和治疗中的重要性。通过现有的抗Aβ疗法和新兴的抗tau方法，预防AD的可能性得以实现。文章还讨论了实施预防试验的挑战及其对临床实践的影响，指出成功的预防策略将显著改变AD的治疗格局，减轻老年人群体的认知衰退负担。
Prognostic value of MYBL2 and its potential implications for immunotherapy: a study of bioinformatics and experimental validation
MYBL2作为MYB转录因子家族的一员，在多种恶性肿瘤中促进肿瘤进展。研究表明，MYBL2在子宫内膜癌中可能作为预后生物标志物，并与免疫细胞浸润相关。通过生物信息学和实验验证，MYBL2的下调显著抑制了癌细胞的生长和迁移，显示出其在癌症免疫治疗中的潜在应用价值。
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression
研究发现WW结构域结合蛋白11（WBP11）在肝细胞癌（HCC）中富集，并预测其不良预后。WBP11通过抑制UFM1特异性连接酶1（UFL1）介导的NONO UFMylation，增强HCC细胞的糖酵解，维持NONO的蛋白稳定性。WBP11的缺失显著抑制HCC细胞的生长和转移，揭示了WBP11-NONO轴在HCC进展中的关键作用，强调了UFMylation在癌症中的重要性，可能为靶向WBP11的新型抗癌策略提供依据。
Heritability and shared environmental effects of brain diseases in 12,040 extended families
该研究分析了来自12040个家庭的脑疾病遗传性和环境影响，发现大多数脑疾病的遗传贡献显著，尤其是阿尔茨海默病和血管性痴呆。研究采用多基因建模方法，提供了对遗传和环境因素的深入理解，强调了公共卫生政策在降低疾病发生率中的重要性。
A temperature-sensitive CRISPR-Cas12a system for sterile insect technique
本研究提出了一种温度敏感的CRISPR-Cas12a系统，用于诱导果蝇的雄性不育和雌性致死，展示了其在控制病媒昆虫方面的潜力。该系统在不同温度下表现出显著的基因编辑活性，可能为全球范围内的病媒控制策略提供新的解决方案。
Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming
KRAS mutations are prevalent in various cancers and play a crucial role in immune suppression and tumor progression. The article reviews how these mutations remodel the immune microenvironment and metabolic pathways, leading to challenges in treatment. It highlights ongoing clinical trials for targeted therapies against KRAS mutations, suggesting significant potential for investment in this area of oncology.
JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer
JMJD3 is identified as a key regulator in gastric cancer, promoting malignancy and chemotherapy resistance by upregulating ALOX5. This study demonstrates that JMJD3 enhances stemness characteristics in gastric cancer cells, making them more resistant to treatment. Importantly, the findings suggest that targeting JMJD3 could improve the efficacy of existing therapies by increasing sensitivity to ferroptosis inducers, offering a promising avenue for future gastric cancer treatments.
Astragali Radix-Carthami Flos alleviate brain-heart injury after cerebral ischemia/reperfusion via regulating TSPO signaling
Astragali Radix-Carthami Flos (ARCF) has shown promise in alleviating brain-heart injury following cerebral ischemia/reperfusion (CI/R) by regulating TSPO signaling. In a rat model, ARCF treatment improved neurological function and cardiac health, suggesting its potential as a therapeutic intervention for stroke-related complications. The study utilized transcriptomic analysis to identify key pathogenic mechanisms, highlighting oxidative phosphorylation and reactive oxygen species (ROS) production. TSPO emerged as a central target, indicating that ARCF may offer a novel approach to managing neurocardiac complications.
RNA sequencing reveals novel lncRNA modulators in gemini nanocurcumin–treated colorectal cancer cells
本研究通过RNA测序揭示了Gemini纳米姜黄素在结直肠癌细胞中的作用，发现了9805个差异表达的lncRNA，并分析了其在细胞周期、p53信号通路等中的功能。研究结果表明，Gemini-Cur可能通过调节特定的lncRNA来增强治疗效果，为结直肠癌的治疗提供了新的潜在靶点和机制。
Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia
本研究探讨了25(OH)D3作为一种天然类固醇激素在急性前髓细胞白血病（APL）患者分化综合症中的潜在治疗作用。研究发现，25(OH)D3能够显著降低NF-κB活性，并减少与分化综合症相关的细胞因子水平，显示出其作为联合治疗的前景。这一发现为APL的治疗提供了新的思路，可能改善患者的临床结果。
The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression
研究表明Hippo-YAP信号通路通过诱导FHL3表达促进肝细胞癌的进展。FHL3的高表达与肝细胞癌患者的预后不良相关，且通过KRAS信号通路影响肿瘤的增殖和转移。这一发现为肝细胞癌的治疗提供了新的靶点，具有重要的临床和商业价值。
m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
FTO作为一种m6A去甲基化酶，在胰腺导管腺癌（PDAC）中发挥关键作用，调节PFKM介导的糖酵解，促进肿瘤的发生和转移。研究通过多组学整合分析，揭示了FTO在PDAC细胞迁移和侵袭中的重要性，且PFKM的表达与患者预后显著相关。这些发现为PDAC的治疗提供了新的靶点，具有重要的临床和商业潜力。